Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24

PURPOSE: The NSABP (National Surgical Adjuvant Breast and Bowel Project) B-24 study demonstrated significant benefit with adjuvant tamoxifen in patients with ductal carcinoma in situ (DCIS) after lumpectomy and radiation. Patients were enrolled without knowledge of hormone receptor status. The curre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Allred, D. Craig, Anderson, Stewart J., Paik, Soonmyung, Wickerham, D. Lawrence, Nagtegaal, Iris D., Swain, Sandra M., Mamounas, Elefetherios P., Julian, Thomas B., Geyer, Charles E., Costantino, Joseph P., Land, Stephanie R., Wolmark, Norman
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2012
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3341142/
https://ncbi.nlm.nih.gov/pubmed/22393101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.34.0141
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados